- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Faculty Research and Publications /
- Statin’s benefit for secondary prevention confirmed...
Open Collections
UBC Faculty Research and Publications
Statin’s benefit for secondary prevention confirmed : What is the optimal dosing strategy? Therapeutics Initiative (University of British Columbia)
Description
Therapeutics Letter 49 discusses optimal dosing strategies for statins for secondary prevention. Conclusions: Statins provide a cardiovascular and total mortality benefit for patients with clinically evident occlusive vascular disease (secondary prevention) and a cholesterol of >3.5 mM. Large RCTs are required to test different statin dosing strategies for secondary prevention before making firm recommendations.
Item Metadata
Title |
Statin’s benefit for secondary prevention confirmed : What is the optimal dosing strategy?
|
Alternate Title |
Therapeutics Letter 49
|
Creator | |
Date Issued |
2003-09
|
Description |
Therapeutics Letter 49 discusses optimal dosing strategies for statins for secondary prevention. Conclusions: Statins provide a cardiovascular and total mortality benefit for patients with clinically evident occlusive vascular disease (secondary prevention) and a cholesterol of >3.5 mM. Large RCTs are required to test different statin dosing strategies for secondary prevention before making firm recommendations.
|
Subject | |
Genre | |
Type | |
Language |
eng
|
Notes |
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
|
Date Available |
2023-06-20
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0433628
|
URI | |
Affiliation | |
Peer Review Status |
Reviewed
|
Scholarly Level |
Faculty; Researcher
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International